Real-world evidence (RWE) has become a crucial driver of the pharmaceutical and biotechnology industries in recent years. In fact, RWE is now included in 70 percent of new drug and biologic regulatory ...
Real-world data is increasingly used to optimize trial design, reduce recruitment burden, and support regulatory decisions, but adoption remains uneven due to challenges around data quality, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results